Immunoglobulin κ gene rearrangements between the κ deleting element and Jκ recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis

Leukemia

Volumn 14, Issue 4, 2000, Pages 671-674

  Seriu, T ^a,b   Hansen Hagge, T E ^a,c   Stark, Y ^a   Bartram, C R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Acute lymphoblastic leukemia; Ig hybrid joint; Minimal residual disease

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; SIGNAL PEPTIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; GENE REARRANGEMENT; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; INTRON; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL;

EID: 0034079057     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401745     Document Type: Article

References (21)

1. Korsmeyer SJ, Hieter PA, Ravetch JV, Poplack DG, Waldmann TA, Leder P. Developmental hierarchy of immunological gene rearrangements in human leukemic pre-B cells. Proc Natl Acad Sci USA 1981; 78: 7096-7100.
2. Hieter PA, Korsmeyer SJ, Waldmann TA, Leder P. Human immunoglobulin κ light-chain genes are deleted or rearranged in λ-producing B cells. Nature 1981; 290: 368-372.
3. Siminovitch KA, Bakhshi A, Goldman P, Korsmeyer SG. A uniform deleting element mediates the loss of κ genes in human B cells. Nature 1985; 316: 260-262.
4. Klobeck H-G, Zachau HG. The human Cκ gene segment and the kappa deleting element are closely linked. Nucleic Acids Res 1988; 14: 4591-4603.
5. Graninger WB, Goldman PL, Morton CC, O'Brien SJ, Korsmeyer SJ. The kappa-deleting element. Germline and rearranged, duplicated and dispersed forms. J Exp Med 1988; 167: 488-501.
6. Schäble KF, Zachau HG. The variable genes of the human immunoglobulin κ locus. Biol Chem Hoppe-Seyler 1993; 374: 1001-1022.
7. Feddersen RM, Martin DJ, van Ness BG. Novel recombinations in the Ig κ-locus that result in allelic exclusion. J Immunol 1990; 145: 745-750.
8. Beishuizen A, Verhoeven MAJ, Mol EJ, van Dongen JJM. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis. Leukemia 1994; 8: 2228-2236.
9. Beishuizen A, de Bruijn MAC, Pongers-Willemse MJ, Verhoeven MAJ, van Wering ER, Hählen K, Breit TM, de Bruin-Versteeg S, Hooijkaas H, van Dongen JJM. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia 1997; 11: 2200-2207.
10. Van Dongen JJM, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig W-D, Basso G, de Bruijn MAC, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WCJ, Riehm H, Bartram CR. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731-1738.
11. Pongers-Willemse MJ, Seriu T, Stolz F, Corral L, Gameiro P, Pisa P, Gonzales M, Bartram CR, Panzer-Grumayer ER, Biondi A, San Miguel IF, van Dongen JJM. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Leukemia 1999; 13: 110-118.
12. Ludwig W-D, Bartram CR, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt-Jung H, Teichmann JV, Riehm H. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988; 71: 1518-1528.
13. van der Does-van der Berg A, Bartram CR, Basso G, Benoit YCM, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Köller U, Lampert F, Ludwig W-D, Niemeyer CM, van Wering ER. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM family' cooperative group. Med Ped Oncol 1992; 20: 497-505.
14. Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E, Bartram CR. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331-339.
15. van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T-cell receptor genes. Part 1: basic and technical aspects. Clin Chim Acta 1991; 198: 1-91.
16. Seriu T, Hansen-Hagge TE, Erz DHR, Bartram CR. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions. Leukemia 1995; 9: 316-320.
17. Lewis SM, Hesse JE, Mizuuchi K, Gellert M. Novel strand exchanges in V(D)J recombination. Cell 1988; 55: 1099-1107.
18. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological and comparative analysis. Adv Immunol 1994; 56: 27-150.
19. Bogue M, Roth DB. Mechanism of V(D)J recombination. Curr Opin Immunol 1996; 8: 175-180.
20. Whitehurst C, Henney HR, Max EE, Schroeder Jr HW, Stüber F, Siminovitch KA, Garrard WT. Nucleotide sequence of the intron of the germline human κ immunoglobulin gene connecting the J and C regions reveals a matrix association region (MAR) next to the enhancer. Nucleic Acids Res 1992; 20: 4929-4930.
21. Xu Y, Davidson L, Alt FW, Baltimore D. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish VκJκ rearrangement. Immunity 1996; 4: 377-385.